Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
Add more filters










Publication year range
1.
Mutagenesis ; 22(6): 363-70, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17656635

ABSTRACT

Quaternary ammonium compounds (QACs) are cationic surfactants that are widely used as disinfectants. In the present study, we tested two important representatives, namely, benzalkonium chloride (BAC) and dimethyldioctadecyl-ammonium bromide (DDAB) in four genotoxicity tests, namely, in the Salmonella/microsome assay with strains TA 98, TA 100 and TA 102, in the single-cell gel electrophoresis (SCGE) assay with primary rat hepatocytes and in micronucleus (MN) assays with peripheral human lymphocytes and with root tip cells of Vicia faba. In the bacterial experiments, consistently negative results were obtained in the dose range between 0.001 and 110 microg per plate in the presence and absence of metabolic activation while significant induction of DNA migration was detected in the liver cells. With BAC, a moderate but significant effect was found with an exposure concentration of 1.0 mg/l while DDAB caused damage at lower doses (0.3 mg/l). The effects were not altered when the nuclei were treated with formamidopyridine glycosylase, indicating that they are not due to formation of oxidized purines. The MN assays with blood cells were carried out under identical conditions to the SCGE experiments and a significant increase was seen at the highest dose levels (BAC: 1.0 and 3.0 mg/l; DDAB: 1 mg/l). Both compounds also caused significant induction of MN as well as inhibition of cell division in plant cells, the lowest effective levels were 1.0 and 10 mg/l for DDAB and BAC, respectively. Our findings show that both chemicals induce moderate but significant genotoxic effects in eukaryotic cells at concentrations which are found in wastewaters and indicate that their release into the environment may cause genetic damage in exposed organisms. Furthermore, the direct contact of humans to QAC-containing detergents and pharmaceuticals that contain substantially higher concentrations than those which were required to cause effects in eukaryotic cells in the present study should be studied further in regard to potential DNA-damaging effects in man.


Subject(s)
Anti-Infective Agents, Local/toxicity , Benzalkonium Compounds/toxicity , Hepatocytes/drug effects , Lymphocytes/drug effects , Quaternary Ammonium Compounds/toxicity , Salmonella typhimurium/drug effects , Vicia faba/drug effects , Adult , Animals , Cells, Cultured , Humans , Lymphocytes/metabolism , Male , Micronucleus Tests , Mutagenicity Tests , Rats , Tumor Cells, Cultured , Vicia faba/growth & development
2.
Br J Cancer ; 91(11): 1955-63, 2004 Nov 29.
Article in English | MEDLINE | ID: mdl-15534611

ABSTRACT

The pro-peptide of transforming growth factor alpha (proTGFalpha) was recently found in hepatocyte nuclei preparing for DNA replication, which suggests a role of nuclear proTGFalpha for mitogenic signalling. This study investigates whether the nuclear occurrence of the pro-peptide is involved in the altered growth regulation of (pre)malignant hepatocytes. In human hepatocarcinogenesis, the incidence of proTGFalpha-positive and replicating nuclei gradually increased from normal liver, to dysplastic nodules, to hepatocellular carcinoma. ProTGFalpha-positive nuclei almost always were in DNA synthesis. Also, in rat hepatocarcinogenesis, proTGFalpha-positive nuclei occurred in (pre)malignant hepatocytes at significantly higher incidences than in unaltered hepatocytes. For functional studies unaltered (GSTp(-)) and premalignant (GSTp(+)) rat hepatocytes were isolated by collagenase perfusion and cultivated. Again, DNA synthesis occurred almost exclusively in proTGFalpha-positive nuclei. GSTp(+) hepatocytes showed an approximately 3-fold higher frequency of proTGFalpha-positive nuclei and DNA replication than GSTp(-) cells. Treatment of cultures with the mitogen cyproterone acetate (CPA) elevated the incidence of proTGFalpha-positive nuclei and DNA synthesis in parallel. Conversely, transforming growth factor beta1 (TGFbeta1) lowered both. These effects of CPA and TGFbeta1 were significantly more pronounced in GSTp(+) than in GSTp(-) hepatocytes. In conclusion, nuclear translocation of proTGFalpha increases in the course of hepatocarcinogenesis and appears to be involved in the inherent growth advantage of (pre)malignant hepatocytes.


Subject(s)
Cell Nucleus/metabolism , DNA/metabolism , Hepatocytes/cytology , Liver Neoplasms/pathology , Precancerous Conditions/pathology , Transforming Growth Factor alpha/metabolism , Animals , Antineoplastic Agents/pharmacology , Cyproterone Acetate/pharmacology , DNA Replication , Glutathione Transferase/metabolism , Hepatocytes/drug effects , Hepatocytes/metabolism , Liver Neoplasms/metabolism , Male , Precancerous Conditions/metabolism , Protein Transport , Rats , Rats, Wistar , Transforming Growth Factor beta/pharmacology , Transforming Growth Factor beta1
3.
Food Chem Toxicol ; 40(8): 1185-9, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12067582

ABSTRACT

Dioxins are highly toxic by-products of incineration processes and of production of chloro-organic chemicals. Accidental poisonings have occurred repeatedly. The main human exposure is via the dietary route. Species comparisons of toxic effects on the basis of ingested doses are not possible because of the highly differing toxicokinetics between humans and experimental animals. On the basis of internal doses or body burdens acute toxic and tumorigenic responses are observed at similar levels in humans and rats. PCB/PCDD/F contamination at levels which have been reported of marketed chicken meat and eggs in 1999 in Belgium may have increased body burdens by approximately 10%. However, it is estimated that a several hundred-fold higher uptake would be necessary to reach body burdens leading to overt toxicity in normal human subjects.


Subject(s)
Dioxins/toxicity , Food Contamination/analysis , Polychlorinated Dibenzodioxins/analogs & derivatives , Animals , Benzofurans/analysis , Benzofurans/pharmacokinetics , Benzofurans/toxicity , Body Burden , Chickens , Dioxins/analysis , Dioxins/pharmacokinetics , Eggs/analysis , Environmental Exposure , Humans , Meat/analysis , Polychlorinated Biphenyls/analysis , Polychlorinated Biphenyls/pharmacokinetics , Polychlorinated Biphenyls/toxicity , Polychlorinated Dibenzodioxins/analysis , Polychlorinated Dibenzodioxins/pharmacokinetics , Polychlorinated Dibenzodioxins/toxicity , Polymers/analysis , Polymers/pharmacokinetics , Polymers/toxicity , Risk Assessment
4.
Mutat Res ; 495(1-2): 89-96, 2001 Aug 22.
Article in English | MEDLINE | ID: mdl-11448646

ABSTRACT

Musk ketone is a widely used artificial fragrance which has been identified in human fatty tissue and milk. The mutagenic and comutagenic effects of this compound were studied in micronucleus tests with a human derived hepatoma cell line (Hep G2). Exposure of the cells to MK alone in the range between 5 and 5000 ng/ml did not cause induction of MN. When the cells were treated simultaneously with MK (5-5000 ng/ml) and 0.2 microg/ml benzo(a)pyrene, no synergistic effects were detected; benzo(a)pyrene (B(a)P) itself caused an 1.5-fold increase of MN over the spontaneous background frequency (60 versus 39 MN/1000 binucleated cells). In a third experimental series, the cells were pretreated with MK for 28h and subsequently exposed to 0.2 microg/ml B(a)P. In this case, a pronounced comutagenic effect was observed: The LOAEL for MK was 0.05 microg/ml. With higher doses (0.5, 1.0 and 5.0 microg MK/ml), a significant increase of B(a)P induced MN frequencies was measured, the induction rates being 50, 66, and 88%, respectively. Additional measurements of 7-ethoxyresorufin deethylase indicated that MK induces cytochrome P450 isoenzymes (1A1) which play a key role in the activation of B(a)P. The results of the present study show that MK amplifies the genotoxic effects of B(a)P in human derived cells and indicate that exposure of humans to MK might increase their susceptibility to the health hazards of B(a)P and other polycyclic aromatic hydrocarbons.


Subject(s)
Benzo(a)pyrene/toxicity , Mutagens/toxicity , Perfume/toxicity , Xylenes/toxicity , Benzo(a)pyrene/metabolism , Carcinoma, Hepatocellular , Cytochrome P-450 CYP1A1/biosynthesis , Dose-Response Relationship, Drug , Drug Synergism , Enzyme Induction , Humans , Micronucleus Tests , Tumor Cells, Cultured/cytology , Tumor Cells, Cultured/drug effects
5.
Carcinogenesis ; 22(8): 1247-56, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11470756

ABSTRACT

The role of transforming growth factor alpha (TGFalpha) and prostaglandins (PGs) in the preferential growth of preneoplastic liver cells was studied. Rats received the genotoxic hepatocarcinogen N-nitrosomorpholine (NNM); placental glutathione S-transferase (GSTp) was used as a marker to identify preneoplastic foci. Preneoplastic foci expressing TGFalpha (TGFalpha(+)) grew more rapidly than TGFalpha negative (TGFalpha(-)) ones. Almost all tumours studied were positive for TGFalpha. The key enzymes of prostaglandin synthesis, cyclooxygenase I (Cox-1) and II (Cox-2), were present in all unaltered and preneoplastic cells and tended to decrease in the later stages of hepatocarcinogenesis. Immunostaining revealed that cultures of hepatocytes, isolated from NNM-treated livers by collagenase perfusion, contained 1-2% GSTp-positive (GSTp(+)) and 9% TGFalpha(+) hepatocytes; 0.6% of the cells were GSTp(+)/TGFalpha(+). Cox-1 and Cox-2 were present in all cells. DNA replication was almost exclusively associated with expression of TGFalpha. GSTp(+) hepatocytes showed a 3- to 4-fold higher probability of TGFalpha expression and of DNA synthesis than GSTp-negative (GSTp(-)) cells. PGE(2) or PGF(2alpha) increased expression of TGFalpha and DNA replication in GSTp(-) cells but not in GSTp(+) cells. PGA(2) and PGJ(2) decreased DNA synthesis in TGFalpha(+) cells without an obvious effect on the intracellular levels of TGFalpha. The Cox-2 inhibitor SC236 suppressed DNA replication preferentially in GSTp(+) cells; this inhibition was reversed by PGE(2)/F(2alpha). Indomethacin had no effect. These results suggest the following conclusions. (i) Growth regulation of preneoplastic GSTp(+) cells in culture exhibits distinct differences from GSTp(-) cells and elevated expression of TGFalpha contributes to their growth advantage. (ii) TGFalpha renders preneoplastic hepatocytes sensitive to suppression of DNA synthesis by PGA(2)/J(2). (iii) SC236, a Cox-2 inhibitor, may have preventive value in hepatocarcinogenesis.


Subject(s)
Cell Division/physiology , Hepatocytes/cytology , Liver Neoplasms, Experimental/pathology , Precancerous Conditions/pathology , Prostaglandins/physiology , Transforming Growth Factor alpha/physiology , Animals , Apoptosis/drug effects , Cell Division/drug effects , Cyclooxygenase Inhibitors/pharmacology , DNA Replication/drug effects , DNA Replication/physiology , Glutathione Transferase/metabolism , Liver Neoplasms, Experimental/enzymology , Liver Neoplasms, Experimental/genetics , Male , Precancerous Conditions/enzymology , Precancerous Conditions/genetics , Rats , Rats, Wistar
6.
Carcinogenesis ; 22(3): 519-23, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11238195

ABSTRACT

There have been numerous reports that chemicals which induce peroxisomes in rodent liver increase DNA synthesis in isolated hepatic parenchymal cells, but not as well in vitro as in vivo. It is also known that tumour necrosis factor alpha (TNFalpha) is mitogenic in isolated hepatocytes. Since Kupffer cells are a major source of TNFalpha in the liver and have recently been shown to be activated by peroxisome proliferators, the possibility exists that the effect of peroxisome proliferators on DNA synthesis in parenchymal cells is via Kupffer cell contamination of isolated hepatocyte preparations. The purpose of this study was to evaluate this hypothesis by studying the effect of model peroxisome proliferators on purified hepatocyte preparations. Hepatocytes were prepared from rat liver by standard calcium-free and collagenase perfusion. Subsequently, cells were centrifuged through Percoll to remove contaminating non-parenchymal cells. Cells were at least 99.9% pure as assessed by cell counting using specific markers for hepatocytes (resorufin O-glucoside) and Kupffer cells (FITC-labelled latex beads). Hepatocytes were cultured in Williams medium + 10% fetal bovine serum for 24 h followed by culture for 48 h in Williams medium plus or minus drug or mitogen additions. Under these conditions epidermal growth factor stimulated DNA synthesis assessed by incorporation of [3H]thymidine approximately 5-fold over control levels. The peroxisome proliferators WY,14-643 and nafenopin, however, had no effect on DNA synthesis, although they did increase acyl-CoA oxidase as expected. In contrast, TNFalpha increased cell proliferation nearly 10-fold in purified hepatocytes, an effect nearly doubled by WY-14,643. Further, when conditioned medium from purified Kupffer cells incubated with WY-14,643 was added to pure hepatocytes, DNA synthesis was increased over 2-fold in a time-dependent manner. Collectively, these data support the hypothesis that peroxisome proliferators do not influence DNA synthesis in isolated hepatocytes per se. Rather, they stimulate cytokine production by Kupffer cells which in turn increases DNA synthesis in parenchymal cells. An increase in mitogenic cytokine production by Kupffer cells is necessary for stimulation of DNA synthesis in purified rat parenchymal cells.


Subject(s)
DNA Replication/drug effects , Hepatocytes/drug effects , Peroxisome Proliferators/pharmacology , Animals , Hepatocytes/metabolism , Kupffer Cells/drug effects , Kupffer Cells/metabolism , Nafenopin/pharmacology , Pyrimidines/pharmacology , Rats
7.
Mutat Res ; 463(1): 13-31, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10838207

ABSTRACT

Human biomonitoring using the single cell gel electrophoresis (SCGE) or comet assay is a novel approach for the assessment of genetic damage in exposed populations. This assay enables the detection of various forms of DNA damage in individual cells with ease and speed and is, therefore, well suited to the analysis of a large group in a population. Here, application of SCGE assay in the identification of dietary protective factors, in clinical studies and in monitoring the risk of DNA damage resulting from occupational, environmental or lifestyle exposures is reviewed. Also, the comparative sensitivity of SCGE assay and conventional cytogenetic tests to detect genetic damage is discussed. Finally, strengths and shortcomings of the SCGE assay are addressed.


Subject(s)
Comet Assay/standards , DNA Damage , Dietary Supplements/statistics & numerical data , Genetic Testing/methods , Adolescent , Adult , Aged , Aged, 80 and over , Antioxidants/pharmacokinetics , Biological Availability , Child , Comet Assay/methods , DNA Damage/physiology , Environmental Exposure/adverse effects , Environmental Exposure/statistics & numerical data , Female , Humans , Infant, Newborn , Life Style , Male , Occupational Exposure/adverse effects , Occupational Exposure/statistics & numerical data , Sensitivity and Specificity , Thyroid Neoplasms/diagnosis , Urinary Bladder Neoplasms/diagnosis , Urinary Bladder Neoplasms/drug therapy
8.
Crit Rev Toxicol ; 30(1): 1-69, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10680768

ABSTRACT

Over the last 30 years approximately 160 reports have been published on dietary compounds that protect from the mutagenic and carcinogenic effects of heterocyclic aromatic amines (HAAs). In the first section of this review, the current state of knowledge is briefly summarized. Based on the evaluation of the available data, various protective mechanisms are described, and the use of different methodologies for the detection of protective effects is critically discussed. In most antimutagenicity studies (>70%) bacterial indicators (predominantly Salmonella strain TA98) were used, and about 600 individual compounds and complex mixtures have been identified that attenuate the effects of HAAs. The most frequently used in vivo method to detect protective effects are adduct measurements; anticarcinogenic dietary factors were identified by aberrant crypt foci assays and liver foci tests with rats. The mechanisms of protection include inactivation of HAAs and their metabolites by direct binding, inhibition of enzymes involved in the metabolic activation of the amines, induction of detoxifying enzymes, and interaction with DNA repair processes. The detection spectrum of conventional in vitro mutagenicity assays with metabolically incompetent indicator cells is limited. These procedures reflect only simple mechanisms such as direct binding of the HAAs to pyrroles and fibers. It has been shown that these compounds are also effective in rodents. More complex mechanisms, namely, interactions with metabolic activation reactions are not adequately represented in in vitro assays with exogenous enzyme homogenates, and false-negative as well as false-positive results may be obtained. More appropriate approaches for the detection of protective effects are recently developed test systems with metabolically competent cells such as the human Hep G2 line or primary hepatocytes. SCGE tests and DNA adduct measurements with laboratory rodents enable the detection of antigenotoxic effects in different organs, including those that are targets for tumor induction by the amines. Medium term assays based on aberrant crypt foci in colon and liver foci tests have been used to prove that certain compounds that prevented DNA damage by HAAs also reduced their carcinogenic effects. These experiments are costly and time consuming and, due to the weak induction capacity of the amines, only pronounced anticarcinogenic effects can be detected. Over the years, a large bulk of data on HAA protective compounds has accumulated, but only for a few (e.g., fibers, pyrroles, constituents of teas, and lactic acid bacteria) is there sufficient evidence to support the assumption that they are protective in humans as well.


Subject(s)
Amines/toxicity , Anticarcinogenic Agents/pharmacology , Antimutagenic Agents/pharmacology , Carcinogens/toxicity , Heterocyclic Compounds/toxicity , Mutagens/toxicity , Animals , Humans , In Vitro Techniques
9.
Carcinogenesis ; 21(1): 79-86, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10607737

ABSTRACT

To study growth regulation in the beginning of carcinogenesis, we established a novel ex vivo model for co-cultivation of normal and putatively initiated hepatocytes. Rats received the genotoxic hepatocarcinogen N-nitrosomorpholine (NNM). This led to the appearance of hepatocytes expressing placental glutathione S-transferase (G(+) cells). These cells exhibited elevated rates of cell replication and apoptosis, as known from further advanced preneoplasia; G(+) cells were considered initiated. At days 20-22 post-NNM treatment their frequency was maximal (1-2%); approximately 40% were still single and 60% were arranged in mini foci. At this time-point liver cells were isolated by collagenase perfusion and cultivated. G(+) cells, identified by immunostaining of the culture-plates, were present at the same percentage as in vivo, excluding selective loss, enrichment or spontaneous expression of the G(+) phenotype. In untreated cultures G(+) hepatocytes showed significantly higher rates of replicative DNA synthesis than normal G(-) cells. Application of the hepatomitogen cyproterone acetate (CPA) elevated DNA replication preferentially in G(+) cells. Transforming growth factor beta1 (TGF-beta1) suppressed replicative DNA synthesis which was more pronounced in G(+) than in G(-) hepatocytes. Combined treatment with CPA and TGF-beta1 had no effect on G- cells, but considerably inhibited DNA replication in G(+) cells. This suggests that the effects of TGF-beta1 predominated in G(+) hepatocytes. We conclude that putatively initiated G(+) hepatocytes, both in vivo and in culture, exhibit higher basal rates of DNA replication than normal G(-) hepatocytes and an over-response to mitogens and growth inhibitors. Therefore, G(+) cells show (i) nearly identical behaviour in intact liver and in primary culture and (ii) inherent defects in growth control that are principally similar although somewhat less pronounced than in later stages of carcinogenesis. The present ex vivo system thus provides a novel and useful tool to elucidate biological and molecular changes during initiation of carcinogenesis.


Subject(s)
Liver Neoplasms/etiology , Liver/pathology , Precancerous Conditions/etiology , Animals , Cell Division/drug effects , Cells, Cultured , Cyproterone Acetate/pharmacology , DNA/biosynthesis , Glutathione Transferase/metabolism , Liver/drug effects , Liver/enzymology , Male , Nitrosamines/toxicity , Phenobarbital/pharmacology , Phenotype , Rats , Rats, Wistar , Transforming Growth Factor beta/pharmacology
10.
Mutagenesis ; 14(6): 533-40, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10567027

ABSTRACT

In order to study the mutagenic effects of heterocyclic aromatic amines (HAAs) in cells of human origin, five compounds, namely 2-amino-3-methyl-imidazo[4,5-f]quinoline (IQ), 2-amino-3, 4-dimethyl-imidazo[4,5-f]quinoline (MeIQ), 2-amino-3, 8-dimethyl-imidazo[4,5-f]quinoxaline (MeIQx), the pyridoimidazo derivative 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (Trp-P-1), were tested in micronucleus (MN) assays with a human derived hepatoma (HepG2) cell line. All HAAs caused significant, dose-dependent effects. The activities of IQ, MeIQ, MeIQx and PhIP were similar (lowest effective concentrations 25-50 microM), whereas Trp-P-1 was effective at a dose of >/=2.1 microM. In addition, the HAAs were tested in MN assays with Chinese hamster ovary (CHO) cells and in Salmonella strain YG1024 using HepG2 cell homogenates as an activation mix. In the CHO experiments, positive results were obtained with Trp-P-1 and PhIP, whereas the other compounds were devoid of activity under all experimental conditions. The discrepancy in the responsivity of the two cell lines is probably due to differences in their acetylation capacity: enzyme measurements with 2-aminofluorene as a substrate revealed that the cytosolic acetyltransferase activity in the HepG2 cells is approximately 40-fold higher than that of the CHO cells. In the bacterial assays all five HAAs gave positive results but the ranking order was completely different from that seen in the HepG2/MN experiments (IQ > MeIQ > Trp-P-1 >/= MeIQx >> PhIP) and the mutagenic potencies of the various compounds varied over several orders of magnitude. The order obtained in bacterial tests with rat liver S9 mix was more or less identical to that seen in the tests with HepG2 cell homogenates but the concentrations of the amines required to give positive results were in general substantially lower (10(-5)-10(-1) microM). Overall, the results of the present study indicate that MN/HepG2 tests might reflect the mutagenic effects of HAAs more adequately than other in vitro mammalian cell systems due to the presence of enzymes involved in the metabolic conversion of the amines.


Subject(s)
Amines/toxicity , Heterocyclic Compounds/toxicity , Mutagens/toxicity , Animals , Arylamine N-Acetyltransferase/metabolism , CHO Cells/drug effects , CHO Cells/enzymology , Carbolines/toxicity , Carcinogens/toxicity , Carcinoma, Hepatocellular/enzymology , Carcinoma, Hepatocellular/metabolism , Cell Line , Cell Survival , Cricetinae , Humans , Imidazoles/toxicity , Liver Neoplasms/enzymology , Liver Neoplasms/metabolism , Mutagenicity Tests , Quinolines/toxicity , Quinoxalines/toxicity , Rats , Salmonella/drug effects , Salmonella/genetics , Salmonella/growth & development , Tumor Cells, Cultured
11.
Mutagenesis ; 14(6): 595-604, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10567035

ABSTRACT

Benzyl isothiocyanate (BITC) is contained in cruciferous plants which are part of the human diet. Numerous reports indicate that BITC prevents chemically induced cancer in laboratory animals and it has been postulated that BITC might also be chemoprotective in humans. On the other hand, evidence is accumulating that this compound is a potent genotoxin in mammalian cells by itself. To further elucidate the potential hazards of BITC, we investigated its genotoxic effects in different in vitro genotoxicity tests and in animal models. In in vitro experiments [differential DNA repair assay with Escherichia coli, micronucleus assay with human HepG2 cells and single cell gel electrophoresis (SCGE) assay with hepatocytes and gastrointestinal tract cells] pronounced dose-dependent genotoxic effects were found at low dose levels (

Subject(s)
Antimutagenic Agents/pharmacology , Isothiocyanates/toxicity , Adult , Animals , Cells, Cultured , Dose-Response Relationship, Drug , Electrophoresis, Agar Gel , Free Radical Scavengers/metabolism , Humans , Isothiocyanates/metabolism , Lipid Peroxidation/drug effects , Male , Mice , Mice, Inbred Strains , Micronucleus Tests , Mutagenicity Tests/methods , Rats , Rats, Inbred F344 , Salmonella typhimurium/drug effects , Serum Albumin, Bovine/metabolism , Tumor Cells, Cultured
13.
Mutat Res ; 402(1-2): 185-202, 1998 Jun 18.
Article in English | MEDLINE | ID: mdl-9675276

ABSTRACT

The human hepatoma line (Hep G2) has retained the activities of various phase I and phase II enzymes which play a crucial role in the activation/detoxification of genotoxic procarcinogens and reflect the metabolism of such compounds in vivo better than experimental models with metabolically incompetent cells and exogenous activation mixtures. In the last years, methodologies have been developed which enable the detection of genotoxic effects in Hep G2 cells. Appropriate endpoints are the induction of 6-TGr mutants, of micronuclei and of comets (single cell gel electrophoresis assay). It has been demonstrated that various classes of environmental carcinogens such as nitrosamines, aflatoxins, aromatic and heterocyclic amines and polycyclic aromatic hydrocarbons can be detected in genotoxicity assays with Hep G2 cells. Furthermore, it has been shown that these assays can distinguish between structurally related carcinogens and non-carcinogens, and positive results have been obtained with rodent carcinogens (such as safrole and hexamethylphosphoramide) which give false negative results in conventional in vitro assays with rat liver homogenates. Hep G2 cells have also been used in antimutagenicity studies and can identify mechanisms not detected in conventional in vitro systems such as induction of detoxifying enzymes, inactivation of endogenously formed DNA-reactive metabolites and intracellular inhibition of activating enzymes.


Subject(s)
Antimutagenic Agents/pharmacology , Carcinoma, Hepatocellular/metabolism , Liver Neoplasms/metabolism , Mutagens/toxicity , Animals , Carcinoma, Hepatocellular/enzymology , Carcinoma, Hepatocellular/pathology , Humans , Liver Neoplasms/enzymology , Liver Neoplasms/pathology , Mutagenicity Tests , Tumor Cells, Cultured
14.
Wien Klin Wochenschr ; 110(23): 824-33, 1998 Dec 11.
Article in English | MEDLINE | ID: mdl-10025035

ABSTRACT

INTRODUCTION: This report describes the first study on genotoxic effects of Austrian ground- and drinking waters. Samples from the Mitterndorfer Senke (MS) and the vicinity of Wiener Neustadt were tested over a three years period. The MS is the largest aquifer in Austria. Due to deposition of industrial and community wastes, chemicals have polluted the groundwater in this area. Aim of the present study was to elucidate if consumption of these waters might pose a carcinogenic risk to humans. METHODS: 43 Water samples were tested in a test battery which consisted of bacterial gene mutation assays (Salmonella strains TA100 and TA98), micronucleus (MN) assays with cultures of primary rat hepatocytes and plant bioassays (MN tests with Tradescantia and Vicia faba). For the bacterial assays, the water samples were extracted with XAD resins. RESULTS: In total, 27.9% of the samples caused positive effects; 8 samples were active in Salmonella microsome assays, Strain TA100 was particularly sensitive upon addition of metabolic activation mix (6 positive samples). Four samples were positive exclusively in MN assays with cultures of primary rat hepatocytes; one sample gave positive results in all three bioassays. Finished waters from waterworks were consistently devoid of mutagenic activity under all experimental conditions. DISCUSSION: Overall, only a small fraction of the groundwaters caused mutagenic effects and in all cases the activities were moderate. Comparison of the results of the present study with data obtained in other investigations under similar experimental conditions shows that the genotoxicity of groundwaters of the MS area are lower than the effects caused by ground- and drinking waters from other countries. The fact that no genotoxic activity was detected in any of the finished drinking waters can be taken as an indication that consumption of these waters does not pose a health hazard arising from contamination with genotoxic carcinogens to humans.


Subject(s)
Mutagenicity Tests , Mutagens/adverse effects , Water Pollutants, Chemical/adverse effects , Animals , Humans , Maximum Allowable Concentration , Mutagens/analysis , Rats , Risk Factors , Water Pollutants, Chemical/analysis , Water Supply/analysis
15.
Crit Rev Toxicol ; 27(5): 495-537, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9347226

ABSTRACT

Griseofulvin (GF) has been in use for more than 30 years as a pharmaceutical drug in humans for the treatment of dermatomycoses. Animal studies give clear evidence that it causes a variety of acute and chronic toxic effects, including liver and thyroid cancer in rodents, abnormal germ cell maturation, teratogenicity, and embroyotoxicity in various species. No sufficient data from human studies are available at present to exclude a risk in humans: therefore, attempts were made to elucidate the mechanisms responsible for the toxic effects of GF and to address the question whether such effects might occur in humans undergoing GF therapy. It is well documented that GF acts as a spindle poison and its reproductive toxicity as well as the induction of numerical chromosome aberrations and of micronuclei in somatic cells possibly may result from disturbance of microtubuli formation. Likewise, a causal relationship between aneuploidy and cancer has been repeatedly postulated. However, a critical survey of the data available on aneuploidogenic chemicals revealed insufficient evidence for such an association. Conceivably, other mechanisms may be responsible for the carcinogenic effects of the drug. The induction of thyroid tumors in rats by GF is apparently a consequence of the decrease of thyroxin levels and it is unlikely that such effects occur in GF-exposed humans. The appearance of hepatocellular carcinomas (HCC) in mice on GF-supplemented diet is preceded by various biochemical and morphological changes in the liver. Among these, hepatic porphyria is prominent, it may result from inhibition of ferrochelatase and (compensatory) induction of ALA synthetase. GF-induced accumulation of porphyrins in mouse liver is followed by cell damage and necrotic and inflammatory processes. Similar changes are known from certain human porphyrias which are also associated with an increased risk for HCC. However, the porphyrogenic effect of GF therapy in humans is moderate compared with that in the mouse model, although more detailed studies should be performed in order to clarify this relationship on a quantitative basis. A further important effect of GF-feeding in mice is the formation of Mallory bodies (MBs) in hepatocytes. These cytoskeletal abnormalities occur also in humans, although under different conditions; their appearance is associated with the induction of liver disease and HCC. Chronic liver damage associated with porphyria and MB formation, enhanced cell proliferation, liver enlargement, and enzyme induction all may contribute to the hepatocarcinogenic effect of GF in mice. In conclusion, further investigation is required for adequate assessment of health risks to humans under GF therapy.


Subject(s)
Antifungal Agents/toxicity , Griseofulvin/toxicity , Aneuploidy , Animals , Antifungal Agents/chemistry , Antifungal Agents/pharmacokinetics , Carcinogenicity Tests , Cell Transformation, Neoplastic/chemically induced , Griseofulvin/chemistry , Griseofulvin/pharmacokinetics , Humans , In Vitro Techniques , Liver/drug effects , Liver/pathology , Mice , Mutagenicity Tests , Neoplasms/chemically induced , Neoplasms/pathology , Rats , Reproduction/drug effects , Risk Assessment , Tissue Distribution
16.
Mutagenesis ; 12(4): 297-303, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9237777

ABSTRACT

The effects of dietary bioantimutagens (compounds which have been shown to inhibit mutagenesis via interaction with DNA repair processes) on spontaneous and heterocyclic amine (HCA)-induced micronucleus (MN) frequencies were studied in metabolically competent human hepatoma (Hep-G2) cells. All the compounds tested (coumarin, vanillin, caffeine, tannic acid and cinnamaldehyde) caused a moderate increase of MN numbers in Hep-G2 cells at high concentrations (500 microg/ml); only tannic acid was also active at lower dose levels. In combination experiments with the HCA 2-amino-3-methylimidazo-[3,4-f]quinoline (IQ), post-treatment of the cells with bioantimutagens resulted in a pronounced (75-90%) decrease in MN. The most drastic effects were seen with vanillin, coumarin and caffeine which were active at concentrations < or = 5 microg/ml. Further experiments indicated that these compounds also attenuate the mutagenic effects of other HCAs (PhIP, MeIQ, MeIQx, Trp-P-1).


Subject(s)
Amines/toxicity , Antimutagenic Agents/pharmacology , Carcinoma, Hepatocellular/drug therapy , Carcinoma, Hepatocellular/genetics , Heterocyclic Compounds/toxicity , Acrolein/analogs & derivatives , Acrolein/pharmacology , Benzaldehydes/pharmacology , Caffeine/pharmacology , Carbolines/toxicity , Coumarins/pharmacology , DNA Repair/drug effects , Humans , Hydrolyzable Tannins/pharmacology , Imidazoles/toxicity , Micronucleus Tests , Mutagens/toxicity , Quinolines/toxicity , Tumor Cells, Cultured
17.
Toxicol In Vitro ; 11(5): 579-88, 1997 Oct.
Article in English | MEDLINE | ID: mdl-20654355

ABSTRACT

Active cell death (ACD) comprises several subtypes as indicated by morphology at light- and electron-microscopical level: for example type I ACD or apoptosis, with nuclear condensation, fragmentation, cytoplasmic condensation; type II ACD, nuclear pyknosis, cytoplasmic autophagy. Morphologically different types of cell death are considered to reflect differences in the underlying biochemical and molecular events eventually leading to cell collapse. However, currently no simple biochemical or molecular marker for detection of ACD subtypes is available and, therefore, morphological methods are still required to classify ACD. Sometimes, distinction of ACD from necrosis may be equivocal. Type I ACD occurs in primary hepatocyte cultures treated with TGF-beta1 and in colonie adenoma cell cultures treated with the proteinkinase C inhibitor H7 (1[5-iso-quinolylsulfonyl]-2-methylpiperazine). The anti-survival activity of TGF-beta1 was confirmed in vivo as TGF-beta1 strongly induced apoptosis in normal tissue and in preneoplastic lesions of rat liver. Type II ACD was observed in human mammary carcinoma cells (MCF-7) after treatment with tamoxifen. The anti-survival activity of H7 and of the anti-oestrogens tamoxifen, 4-hydroxy-tamoxifen, ICI 164384 could be dissociated from their anti-proliferative action. In conclusion, cell culture studies provide a means to select compounds with high anti-survival activity for further exploration in preclinical and clinical testing.

18.
Chem Biol Interact ; 102(1): 1-16, 1996 Sep 27.
Article in English | MEDLINE | ID: mdl-8827059

ABSTRACT

Crude juices of eight Brassica vegetables as well as juices and extracts of spices and phytopharmaceutical preparations from cruciferous vegetables were tested for induction of point mutations in Salmonella TA98 and TA100, repairable DNA damage in E.coli K-12 cells and clastogenic effects in mammalian cells. In bacterial assays, all juices caused genotoxic effects in the absence of metabolic activation, the ranking order being: Brussels sprouts > white cabbage > cauliflower > green cabbage > kohlrabi > broccoli > turnip > black radish. In experiments with mammalian cells, six juices induced structural chromosome aberrations. Brussels sprouts, white and green cabbage caused the strongest effects (800 microliters of juice induced a 5-fold increase over the background). In sister chromatid exchange assays, positive results were measured as well, but the effects were less pronounced. With all juices the genotoxic effects seen in mammalian cells were paralleled by a pronounced decrease in cell viability. Column fractionation experiments showed that 70-80% of the total genotoxic activity of the juices is found in the fraction which contains isothiocyanates and other breakdown products of glucosinolates, whereas phenolics and flavonoids contributed to a lesser extent to the overall effects. On the basis of these findings, and considering the negative results obtained with non-cruciferous vegetables (tomato, carrot and green pepper), it seems likely that the genotoxic effects of the juices are due to specific constituents of cruciferous plants such as glucosinolates and/or their breakdown products, in particular, isothiocyanates, which we found previously to be potent genotoxins in bacterial and mammalian cells. Finally, spices (mustards and horse radish paste) and phytopharmaceutical preparations were tested in bacterial assays. Mustards and horse radish caused very weak effects while most of the pharmaceutical preparations gave negative results, except cabbage tablets, which caused a strong and dose dependent induction of his revertants in Salmonella TA100. The present findings clearly indicate that cruciferous vegetables contain DNA damaging constituents. These observations are in contrast to earlier findings, which emphasized the antimutagenic effects of vegetable juices and also raise the question whether greatly increased consumption of Brassica vegetables or their concentrated constituents as a means for cancer prevention is indeed recommendable.


Subject(s)
Brassica/toxicity , Chromosome Aberrations , DNA, Bacterial/drug effects , Sister Chromatid Exchange/drug effects , Spices/toxicity , Animals , Brassica/chemistry , CHO Cells/drug effects , Cell Line, Transformed , Chromosome Aberrations/genetics , Cricetinae , Escherichia coli/drug effects , Escherichia coli/genetics , Female , Hot Temperature , Hydrogen-Ion Concentration , Muntjacs , Mutagenicity Tests , Mutagens/toxicity , Plant Extracts/chemistry , Plant Extracts/toxicity , Plants, Medicinal/chemistry , Salmonella typhimurium/drug effects , Salmonella typhimurium/genetics
19.
Toxicol In Vitro ; 10(2): 183-93, 1996 Apr.
Article in English | MEDLINE | ID: mdl-20650196

ABSTRACT

Enhanced cell proliferation may favour DNA-damaging processes (tumour initiation) as well as the expansion of clones of altered cells (tumour promotion). The latter process appears to be responsible for carcinogenesis by non-genotoxic compounds. We previously have established rat hepatocyte primary cultures under serum-free conditions and studied the effect of the rat liver tumour promoter cyproterone acetate (CPA) on DNA synthesis. It was found that glucocorticoid concentration of 100 nm dexamethasone was necessary for the induction of DNA synthesis. In the present study the growth supporting effect of insulin, glucagon and triiodothyronine (T3) were examined. Pretested concentrations of CPA, pregnenolone-16alpha-carbonitrile (PCN), alpha-hexachlorocyclohexane (HCH), nafenopin (NAF) and phenobarbital (PB) were added for stimulation of DNA synthesis. EGF served as a reference stimulator. Beginning with standard medium concentrations of insulin (7 nM), glucagon (0.4 nM) and triiodothyronine (100 nM) dose-response studies were obtained by leaving all but one of the hormone concentrations constant. DNA synthesis was measured by incorporation of [(3)H]thymidine into DNA. In solvent-treated dimethyl sulfoxide (DMSO) cultures insulin at 6 nM and higher induced a 2.5-fold induction of DNA synthesis. Insulin also enhanced DNA synthesis induced by CPA, HCH, NAF, PCN and EGF but not by phenobarbital (EC(50), 2-3 nm). The effect of glucagon (0.016nm-16nm) appeared to be much less prominent and was observed only at superphysiological concentrations with CPA, PCN, HCH and EGF. DNA synthesis induced by NAF was slightly suppressed at 1.6nm glucagon. T3 did not induce DNA synthesis by itself, nor was there modulation of DNA synthesis induced by rat liver tumour promoters. Thus the so-called hepatotrophic hormones differentially modulate the induction of DNA synthesis by rat liver tumour promoters in primary rat hepatocyte cultures.

20.
Environ Mol Mutagen ; 24(4): 317-24, 1994.
Article in English | MEDLINE | ID: mdl-7851344

ABSTRACT

The genotoxic effects of three chlorohydroxyfuranones (CHFs), 3-chloro-4-(dichloromethyl)-5-hydroxy-2[5H]-furanone (MX), 3-chloro-4-(chloromethyl)-5-hydroxy-2[5H]furanone (CMCF) and 3,4,-dichloro-5-hydroxy-2[5H]furanone (MCA), which are formed as byproducts of water disinfection with chlorine, were investigated in bacterial differential DNA repair assays in vitro and in animal-mediated assays in vivo. As indicators of DNA damage, E. coli K-12 strains were used that differ in their repair capacity (uvrB/recA vs. uvr+/rec+). Liquid incubation of the compounds without metabolic activation caused a pronounced reduction of the viability of the repair-deficient strain relative to the repair-proficient wild-type strain. The order of potency of genotoxic activity in vitro (dose range 0.004-10 micrograms/ml) was MX > CMCF > MCA. Addition of mouse S-9 mix or bovine serum albumin to the incubation mixtures resulted in an almost complete loss of the activity of all three test compounds. In the animal-mediated assays, mixtures of the indicator bacteria were injected intravenously into mice which were subsequently treated with the test compounds (200 mg/kg b.w.). Two hours later, the cells were recovered from various organs and the relative survival frequencies determined. Under these conditions, all three compounds caused pronounced genotoxic effects, MX and CMCF being stronger genotoxins than MCA. The strongest effects were consistently found in the gastrointestinal tract, but statistically significant DNA damage was also observed in indicator cells recovered from lungs, liver, spleen and kidneys. In a further experiment, the effects of lower doses of MX (4.3, 13 and 40 mg/kg) were investigated. In these experiments dose-dependent effects were measured in all organs. CMCF and MA caused only marginal effects at 40 mg/kg except in the stomach where approximately a 50% reduction of relative survival frequency was observed with CMCF. The results of these animal-mediated assays indicate that (i) all three CHFs cause genotoxic effects in the living animal, and (ii) the potencies of the three compounds observed under in vivo conditions are not commensurate with their extremely high activities measured in vitro. One possible explanation for the weaker responses observed in the animal-mediated assays might be that CHFs are inactivated by non-specific protein binding.


Subject(s)
DNA, Bacterial/drug effects , Escherichia coli/drug effects , Furans/toxicity , Mutagens/toxicity , Mutation/drug effects , Analysis of Variance , Animals , Biotransformation , Cell Line , DNA Damage/drug effects , DNA Repair/drug effects , Digestive System/microbiology , Escherichia coli/genetics , Genes, Tumor Suppressor/drug effects , Genes, Tumor Suppressor/genetics , Kidney/microbiology , Liver/microbiology , Lung/microbiology , Male , Mice , Mutagenicity Tests , Mutation/genetics , Protein Binding , Spleen/microbiology , Water Pollutants, Chemical/toxicity , Water Purification
SELECTION OF CITATIONS
SEARCH DETAIL
...